www.bna.com Medical Research Law & Policy Report
HomeIndexTable of CasesFeedbackwww.bna.com

Printable version (PDF) 

INDEX
Vol. 8, No. 1-20, pp. 1-722
Jan. 7, 2009 - Oct. 21, 2009

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

    ILLINOIS
      – Autism, In Brief, 433
      – GINA rules, In Brief, 532
    IN VITRO DIAGNOSTIC DEVICES (IVDs)
    INDIA
      – Clinical trial registration required, 367
      – Unethical human experiments, new laws to address, 316
    INFLUENZA
      – Swine flu
        – – Funding sought by White House, 315
        – – Respirators, Institute of Medicine recommends, 616
      – Vaccine
        – – H1N1, In Brief, 529
        – – New method to make, HHS contracts to develop, 459
    INFORMATION NETWORKS AND TECHNOLOGY
      – Better, faster research due to data sharing predicted by NCI official, 240
      – BNA plans audioconference on health IT funding, 201
      – Genetic test results transmitted between health systems, 666
      – Grants for health informatics award by CDC, 671
      – Internet
    INFORMED CONSENT
      – Blindness blamed on implant trial, suit dismissed (S.D. Ohio), 655
      – Cancer trial consent form evaluated, 523
      – Experimental stent implant, heart patient's claims dismissed (E.D. Pa.), 76; reconsideration denied, 420
      – Heart valves
        – – Repair, clarification, 22
        – – Unapproved heart valve marketing, Grassley (R-Iowa) queries FDA, 376
      – Human tissue product documents, attorney-client privilege waived in suit over illegal use of body parts (D.N.J.), 16
      – Impaired decisionmaking, recommendations approved by HHS panel, 215
      – Pacemaker implanted as part of NIH experiment, failure-to-warn claim may proceed (D. Del.), 389
      – Unfair competition and consumer remedies claims dismissed (S.D. Cal.), 609
      – VA, one-third of consent forms non-compliant, 403
    INSTITUTIONAL REVIEW BOARDS (IRBs)
      – Accountability remains an issue at OHRP, 707
      – Assurances and registration, HHS clarifies policy, 364
      – Clinical trials
        – – Fraudulent clinical trial, IRBs claims House panel conducted illegal sting, 207
        – – Guidance on reporting released by FDA, 39
      – Conflicts of interest, many IRBs lack clear policies, study finds, 273
      – External IRBs, In Brief, 156
      – Fake study, Coast Independent shut down, 333
      – Fla. rule, In Brief, 496
      – GAO says system is vulnerable to ethical manipulation, 227; ramifications of GAO probe, Special Report, 294
      – Liability for violations, OHRP seeks comments, 189
      – Registration
        – – Database, FDA suggests updates, 667
        – – Final rule issued by FDA and OHRP, 41; deadline, In Brief, 589
    INTELLECTUAL PROPERTY
      – Access limited by institutional material transfer agreements, 47
      – Government-funded articles
        See LEGISLATION, FEDERAL, HR 801
      – Ischemia research, Pfizer to appeal trade secrets verdict (Cal. Super. Ct.), 26
      – Obstetrics journal article authorship dispute, summary judgment granted for defendant (E.D. Mich.), 78
      – Patents
      – Stem cell research, In Brief, 23
      – Trademarks, mouse strain for human cell engraftment, infringement alleged (N.D. Cal.), 77
      – Traditional knowledge, WIPO endorse compromise, 709
    INTERNATIONAL DEVELOPMENTS
      See also specific countries
      – Clinical trials, globalization raises issues, 153
      – Russia-U.S. cooperation pact, In Brief, 495
    INTERNET
      – BNA Convergence launched, 401
      – CMS launched health IT website, 459
      – HHS civil rights unit revises web site, 125
      – NIH social science, In Brief, 53
      – Tech transfer, In Brief, 399
    IOWA
      – Physician gifts ban approved by Senate, 248
    IPLEX
      – ALS patients get access, 195
    IRBs
    IVDs (IN VITRO DIAGNOSTIC DEVICES)

Contact the Webmaster at webmaster@bna.com
1801 S. Bell Street, Arlington, VA 22202 - Phone: 1-800-372-1033

Copyright © The Bureau of National Affairs, Inc. All Rights Reserved.